KRT20 and neuroendocrine carcinoma: Most adenocarcinomas from other sites (breast, lung, endometrium) and neuroendocrine carcinomas such as SCLC are essentially negative for CK-20 [40] while most are negative for CK-20, those from the lung are postitive for TTF-1.